Now, Cannabotech, an Israeli biomedical firm that innovates botanical-based solutions for oncology and preventive medicine, has found promising results in an experiment involving its Integrative-Colon product, based on a press release. The formula combines mushroom extracts together with cannabinoids from the cannabis plant, then tested on various subtypes of colon cancer. They found that the ingredients of the formulation acted more effectively compared to isolating the cannabinoids, and that the active ingredients showed great synergy working together. Based on the findings, the Integrative-Colon product was able to kill more than 90% of colon cancer cells
